The You lab at CIMR investigates the molecular mechanisms of DNA/RNA surveillance and the innate immune response system, with the goal of translating the discoveries into new therapies for cancer and autoimmune diseases.
1. Intersection of genome maintenance and RNA surveillance with innate immunity
2. Role of TRPV2 and other ion channels in regulating the cGAS/STING-mediated innate immunity
3. Targeting the TRPV2-STING axis for the treatment of cancer and autoimmune diseases
4. Targeting the NMD pathway for the treatment of cancers harboring spliceosome mutations
1. Identified a novel cytosolic DNA-elicited, Ca2+-mediated signaling pathway that safeguards DNA replication forks to maintain genome stability (Molecular Cell, 2019; Molecular Cell, 2023; Nature Communications, 2024).
2. Uncovered a novel interplay on the endoplasmic reticulum between the ion channel TRPV2 and the innate immune factor STING, revealing a new mechanism that co-regulates Ca2+ dynamics and immune activation (Molecular Cell, 2023; Cell Reports, in revision).
3. Pioneered the development of NMD reporter systems, leading to the identification of novel NMD inhibitors and genetic regulators, and demonstrated that NMD is modulated by intracellular Ca2+ and persistent DNA damage (Nature Medicine, 2014; Journal of Biological Chemistry, 2017).
4. Identified NMD as a promising therapeutic target for cancers with spliceosome mutations (Cancer Research, 2021).